AI may decode kidney tumors from MRI scans, avoiding biopsies

NCT ID NCT07743749

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether artificial intelligence can analyze MRI images to identify the type and aggressiveness of kidney tumors. Researchers will use scans from about 900 adults who have had surgery for kidney tumors, comparing AI predictions with the actual pathology results. The goal is to see if AI can provide a reliable, non-invasive way to assess tumors before treatment, potentially helping doctors plan personalized care without extra procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MRI-based artificial intelligence analysis
What this could lead to
If successful, this could give doctors a non-invasive way to predict kidney tumor type and aggressiveness from MRI scans, potentially guiding treatment decisions without immediate surgery.
What could go wrong
The AI models are still being developed and tested, and their accuracy may not be high enough for real-world use. The study relies on existing MRI data, which may vary in quality, and results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    RECRUITING

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.